カテゴリー： QYResearch, 世界

多嚢胞性卵巣症候群治療の世界市場：規模・現状・予測2019-2025

【英語タイトル】Global Polycystic Ovary Syndrome Treatment Market Size, Status and Forecast 2019-2025

QYResearchが出版した調査資料（DATA909X18844）・商品コード：DATA909X18844
・発行会社（調査会社）：QYResearch
・発行日：2019年11月25日（※2024年版があります。お問い合わせください）
・ページ数：91
・レポート言語：英語
・レポート形式：PDF
・納品方法：Eメール（受注後3営業日）
・調査対象地域：グローバル
・産業分野：医薬品・ヘルスケア
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,900 ⇒換算￥577,200見積依頼/購入/質問フォーム
Multi User（5名様閲覧用）USD5,850 ⇒換算￥865,800見積依頼/購入/質問フォーム
Enterprise License（同一法人内共有可）USD7,800 ⇒換算￥1,154,400見積依頼/購入/質問フォーム
※販売価格オプションの説明
※お支払金額：換算金額（日本円）＋消費税
※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡）
※お支払方法：納品日＋5日以内に請求書を発行・郵送（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能）
※当調査レポートでは、多嚢胞性卵巣症候群治療の世界市場について調査・分析し、多嚢胞性卵巣症候群治療の世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別（経口避妊薬、インスリン抵抗性改善薬、抗うつ薬、オルニチンデカルボキシラーゼ阻害薬、アロマターゼ阻害薬、利尿薬）、用途別（病院薬局、ドラッグストア）、地域別（北米、ヨーロッパ、中国、日本国内、東南アジア、インド、中南米）に区分して市場規模を算出しました。


・レポートの概要
・世界の多嚢胞性卵巣症候群治療市場動向
・主要企業別マーケットシェア
・多嚢胞性卵巣症候群治療の種類別市場規模2014-2019
（経口避妊薬、インスリン抵抗性改善薬、抗うつ薬、オルニチンデカルボキシラーゼ阻害薬、アロマターゼ阻害薬、利尿薬）
・多嚢胞性卵巣症候群治療の用途別市場規模2014-2019
（病院薬局、ドラッグストア）
・多嚢胞性卵巣症候群治療の北米市場：主要企業・種類別/用途別市場規模
・多嚢胞性卵巣症候群治療のヨーロッパ市場：主要企業・種類別/用途別市場規模
・多嚢胞性卵巣症候群治療の中国市場：主要企業・種類別/用途別市場規模
・多嚢胞性卵巣症候群治療の日本国内市場：主要企業・種類別/用途別市場規模
・多嚢胞性卵巣症候群治療の東南アジア市場：主要企業・種類別/用途別市場規模
・多嚢胞性卵巣症候群治療のインド市場：主要企業・種類別/用途別市場規模
・多嚢胞性卵巣症候群治療の中南米市場：主要企業・種類別/用途別市場規模
・主要企業のプロフィール
（Sanofi、Novartis AG、Teva Pharmaceutical Industries Limited 、Addex Therapeutics Ltd. 、BIOCAD、Merck KGaA、AstraZeneca plc.、Bristol Myers Squibb Co. 、Ferring Pharmaceuticals, Inc.、Crinetics Pharmaceuticals, Inc.）
・多嚢胞性卵巣症候群治療の市場規模予測2019-2025
（種類別、用途別、地域別市場予測）
・アナリストの観点・結論
...
【レポートの概要】

Polycystic Ovary Syndrome Treatment means treatment of  a common hormonal endocrine disorder that affects women of child bearing age (15 to 49 years). This disease is characterized by the formation of cysts on the ovaries leading to an insufficiency of the ovulation initiating hormone in the female body.In 2018, the global Polycystic Ovary Syndrome Treatment market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

This report focuses on the global Polycystic Ovary Syndrome Treatment status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Polycystic Ovary Syndrome Treatment development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.

The key players covered in this study
Sanofi
Novartis AG
Teva Pharmaceutical Industries Limited 
Addex Therapeutics Ltd. 
BIOCAD
Merck KGaA
AstraZeneca plc.
Bristol Myers Squibb Co. 
Ferring Pharmaceuticals, Inc.
Crinetics Pharmaceuticals, Inc.

Market segment by Type, the product can be split into
Oral Contraceptives
Insulin Sensitizing Agents
Anti-Depressants
Ornithine Decarboxylase Inhibitors
Aromatase Inhibitors
Diuretics

Market segment by Application, split into
Hospital Pharmacies
Drug Stores

Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global Polycystic Ovary Syndrome Treatment status, future forecast, growth opportunity, key market and key players.
To present the Polycystic Ovary Syndrome Treatment development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Polycystic Ovary Syndrome Treatment are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

【レポートの目次】

Table of Contents

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Polycystic Ovary Syndrome Treatment Market Size Growth Rate by Type (2014-2025)
1.4.2 Oral Contraceptives
1.4.3 Insulin Sensitizing Agents
1.4.4 Anti-Depressants
1.4.5 Ornithine Decarboxylase Inhibitors
1.4.6 Aromatase Inhibitors
1.4.7 Diuretics
1.5 Market by Application
1.5.1 Global Polycystic Ovary Syndrome Treatment Market Share by Application (2019-2025)
1.5.2 Hospital Pharmacies
1.5.3 Drug Stores
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Polycystic Ovary Syndrome Treatment Market Size
2.2 Polycystic Ovary Syndrome Treatment Growth Trends by Regions
2.2.1 Polycystic Ovary Syndrome Treatment Market Size by Regions (2019-2025)
2.2.2 Polycystic Ovary Syndrome Treatment Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis

3 Market Share by Key Players
3.1 Polycystic Ovary Syndrome Treatment Market Size by by Players
3.1.1 Global Polycystic Ovary Syndrome Treatment Revenue by by Players (2014-2019)
3.1.2 Global Polycystic Ovary Syndrome Treatment Revenue Market Share by by Players (2014-2019)
3.1.3 Global Polycystic Ovary Syndrome Treatment Market Concentration Ratio (CR5 and HHI)
3.2 Polycystic Ovary Syndrome Treatment Key Players Head office and Area Served
3.3 Key Players Polycystic Ovary Syndrome Treatment Product/Solution/Service
3.4 Date of Enter into Polycystic Ovary Syndrome Treatment Market
3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application
4.1 Global Polycystic Ovary Syndrome Treatment Market Size by Type (2014-2019)
4.2 Global Polycystic Ovary Syndrome Treatment Market Size by Application (2014-2019)

5 North America
5.1 North America Polycystic Ovary Syndrome Treatment Market Size (2014-2019)
5.2 Polycystic Ovary Syndrome Treatment Key Players in North America
5.3 North America Polycystic Ovary Syndrome Treatment Market Size by Type
5.4 North America Polycystic Ovary Syndrome Treatment Market Size by Application

6 Europe
6.1 Europe Polycystic Ovary Syndrome Treatment Market Size (2014-2019)
6.2 Polycystic Ovary Syndrome Treatment Key Players in Europe
6.3 Europe Polycystic Ovary Syndrome Treatment Market Size by Type
6.4 Europe Polycystic Ovary Syndrome Treatment Market Size by Application

7 China
7.1 China Polycystic Ovary Syndrome Treatment Market Size (2014-2019)
7.2 Polycystic Ovary Syndrome Treatment Key Players in China
7.3 China Polycystic Ovary Syndrome Treatment Market Size by Type
7.4 China Polycystic Ovary Syndrome Treatment Market Size by Application

8 Japan
8.1 Japan Polycystic Ovary Syndrome Treatment Market Size (2014-2019)
8.2 Polycystic Ovary Syndrome Treatment Key Players in Japan
8.3 Japan Polycystic Ovary Syndrome Treatment Market Size by Type
8.4 Japan Polycystic Ovary Syndrome Treatment Market Size by Application

9 Southeast Asia
9.1 Southeast Asia Polycystic Ovary Syndrome Treatment Market Size (2014-2019)
9.2 Polycystic Ovary Syndrome Treatment Key Players in Southeast Asia
9.3 Southeast Asia Polycystic Ovary Syndrome Treatment Market Size by Type
9.4 Southeast Asia Polycystic Ovary Syndrome Treatment Market Size by Application

10 India
10.1 India Polycystic Ovary Syndrome Treatment Market Size (2014-2019)
10.2 Polycystic Ovary Syndrome Treatment Key Players in India
10.3 India Polycystic Ovary Syndrome Treatment Market Size by Type
10.4 India Polycystic Ovary Syndrome Treatment Market Size by Application

11 Central & South America
11.1 Central & South America Polycystic Ovary Syndrome Treatment Market Size (2014-2019)
11.2 Polycystic Ovary Syndrome Treatment Key Players in Central & South America
11.3 Central & South America Polycystic Ovary Syndrome Treatment Market Size by Type
11.4 Central & South America Polycystic Ovary Syndrome Treatment Market Size by Application

12 International Players Profiles
12.1 Sanofi
12.1.1 Sanofi Company Details
12.1.2 Company Description and Business Overview
12.1.3 Polycystic Ovary Syndrome Treatment Introduction
12.1.4 Sanofi Revenue in Polycystic Ovary Syndrome Treatment Business (2014-2019))
12.1.5 Sanofi Recent Development
12.2 Novartis AG
12.2.1 Novartis AG Company Details
12.2.2 Company Description and Business Overview
12.2.3 Polycystic Ovary Syndrome Treatment Introduction
12.2.4 Novartis AG Revenue in Polycystic Ovary Syndrome Treatment Business (2014-2019)
12.2.5 Novartis AG Recent Development
12.3 Teva Pharmaceutical Industries Limited 
12.3.1 Teva Pharmaceutical Industries Limited  Company Details
12.3.2 Company Description and Business Overview
12.3.3 Polycystic Ovary Syndrome Treatment Introduction
12.3.4 Teva Pharmaceutical Industries Limited  Revenue in Polycystic Ovary Syndrome Treatment Business (2014-2019)
12.3.5 Teva Pharmaceutical Industries Limited  Recent Development
12.4 Addex Therapeutics Ltd. 
12.4.1 Addex Therapeutics Ltd.  Company Details
12.4.2 Company Description and Business Overview
12.4.3 Polycystic Ovary Syndrome Treatment Introduction
12.4.4 Addex Therapeutics Ltd.  Revenue in Polycystic Ovary Syndrome Treatment Business (2014-2019)
12.4.5 Addex Therapeutics Ltd.  Recent Development
12.5 BIOCAD
12.5.1 BIOCAD Company Details
12.5.2 Company Description and Business Overview
12.5.3 Polycystic Ovary Syndrome Treatment Introduction
12.5.4 BIOCAD Revenue in Polycystic Ovary Syndrome Treatment Business (2014-2019)
12.5.5 BIOCAD Recent Development
12.6 Merck KGaA
12.6.1 Merck KGaA Company Details
12.6.2 Company Description and Business Overview
12.6.3 Polycystic Ovary Syndrome Treatment Introduction
12.6.4 Merck KGaA Revenue in Polycystic Ovary Syndrome Treatment Business (2014-2019)
12.6.5 Merck KGaA Recent Development
12.7 AstraZeneca plc.
12.7.1 AstraZeneca plc. Company Details
12.7.2 Company Description and Business Overview
12.7.3 Polycystic Ovary Syndrome Treatment Introduction
12.7.4 AstraZeneca plc. Revenue in Polycystic Ovary Syndrome Treatment Business (2014-2019)
12.7.5 AstraZeneca plc. Recent Development
12.8 Bristol Myers Squibb Co. 
12.8.1 Bristol Myers Squibb Co.  Company Details
12.8.2 Company Description and Business Overview
12.8.3 Polycystic Ovary Syndrome Treatment Introduction
12.8.4 Bristol Myers Squibb Co.  Revenue in Polycystic Ovary Syndrome Treatment Business (2014-2019)
12.8.5 Bristol Myers Squibb Co.  Recent Development
12.9 Ferring Pharmaceuticals, Inc.
12.9.1 Ferring Pharmaceuticals, Inc. Company Details
12.9.2 Company Description and Business Overview
12.9.3 Polycystic Ovary Syndrome Treatment Introduction
12.9.4 Ferring Pharmaceuticals, Inc. Revenue in Polycystic Ovary Syndrome Treatment Business (2014-2019)
12.9.5 Ferring Pharmaceuticals, Inc. Recent Development
12.10 Crinetics Pharmaceuticals, Inc.
12.10.1 Crinetics Pharmaceuticals, Inc. Company Details
12.10.2 Company Description and Business Overview
12.10.3 Polycystic Ovary Syndrome Treatment Introduction
12.10.4 Crinetics Pharmaceuticals, Inc. Revenue in Polycystic Ovary Syndrome Treatment Business (2014-2019)
12.10.5 Crinetics Pharmaceuticals, Inc. Recent Development

13 Market Forecast 2019-2025
13.1 Market Size Forecast by Product (2019-2025)
13.2 Market Size Forecast by Application (2019-2025)
13.3 Market Size Forecast by Regions
13.4 North America
13.5 Europe
13.6 China
13.7 Japan
13.8 Southeast Asia
13.9 India
13.10 Central & South America

14 Analyst’s Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details

List of Tables and Figures

Table Polycystic Ovary Syndrome Treatment Key Market Segments
Table Key Players Polycystic Ovary Syndrome Treatment Covered
Table Global Polycystic Ovary Syndrome Treatment Market Size Growth Rate by Type 2018-2025 (Million US$)
Figuer Oral Contraceptives Figures
Table Key Players of Oral Contraceptives
Figuer Insulin Sensitizing Agents Figures
Table Key Players of Insulin Sensitizing Agents
Figuer Anti-Depressants Figures
Table Key Players of Anti-Depressants
Figuer Ornithine Decarboxylase Inhibitors Figures
Table Key Players of Ornithine Decarboxylase Inhibitors
Figuer Aromatase Inhibitors Figures
Table Key Players of Aromatase Inhibitors
Figuer Diuretics Figures
Table Key Players of Diuretics
Table Global Polycystic Ovary Syndrome Treatment Market Size Growth by Application 2019-2025 (Million US$)
Figure Global Polycystic Ovary Syndrome Treatment Market Share by Application in 2018 & 2025
Figure Hospital Pharmacies Case Studies
Figure Drug Stores Case Studies
Figure Polycystic Ovary Syndrome Treatment Report Years Considered
Figure Global Polycystic Ovary Syndrome Treatment Market Size and Growth Rate 2014-2025 (Million US$)
Table Global Polycystic Ovary Syndrome Treatment Market Size by Regions 2019-2025 (Million US$)
Table Global Polycystic Ovary Syndrome Treatment Market Size by Regions 2019-2025 (Million US$)
Table Global Polycystic Ovary Syndrome Treatment Market Share by Regions 2014-2019
Figure Global Polycystic Ovary Syndrome Treatment Market Share by Regions 2014-2019
Figure Global Polycystic Ovary Syndrome Treatment Market Share by Regions in 2018
Table Market Top Trends
Table Key Drivers: Impact Analysis (2019-2025)
Table Key Challenges
Figure PORTER'S FIVE FORCES ANALYSIS
Table Global Polycystic Ovary Syndrome Treatment Revenue by by Players (2014-2019) (Million US$)
Table Global Polycystic Ovary Syndrome Treatment Market Share by by Players (2014-2019)
Figure Global Polycystic Ovary Syndrome Treatment Market Share by by Players in 2018
Table Global Polycystic Ovary Syndrome Treatment by Players Market Concentration Ratio (CR5 and HHI)
Table Key Players Head office and Area Served
Table Key Players Polycystic Ovary Syndrome Treatment Product/Solution/Service
Table Date of Enter into Polycystic Ovary Syndrome Treatment Market
Table Mergers & Acquisitions, Expansion Plans
Table Global Polycystic Ovary Syndrome Treatment Market Size by Type (2014-2019) (Million US$)
Table Global Polycystic Ovary Syndrome Treatment Market Size Share by Type (2014-2019)
Figure Global Polycystic Ovary Syndrome Treatment Market Size Market Share by Type (2014-2019)
Table Global Polycystic Ovary Syndrome Treatment Market Size by Application (2014-2019) (Million US$)
Table Global Polycystic Ovary Syndrome Treatment Market Size Share by Application (2014-2019)
Figure Global Polycystic Ovary Syndrome Treatment Market Size Market Share by Application (2014-2019)
Figure Global Polycystic Ovary Syndrome Treatment Revenue Market Share by Application in 2018
Figure North America Polycystic Ovary Syndrome Treatment Market Size 2014-2019 (Million US$)
Table North America Key Players Polycystic Ovary Syndrome Treatment Revenue (2018-2019) (Million US$)
Table North America Key Players Polycystic Ovary Syndrome Treatment Market Share (2018-2019)
Table North America Polycystic Ovary Syndrome Treatment Market Size by Type 2014-2019 (Million US$)
Table North America Polycystic Ovary Syndrome Treatment Market Share by Type 2014-2019
Table North America Polycystic Ovary Syndrome Treatment Market Size by Application 2014-2019 (Million US$)
Table North America Polycystic Ovary Syndrome Treatment Market Share by Application 2014-2019
Figure Europe Polycystic Ovary Syndrome Treatment Market Size 2014-2019 (Million US$)
Table Europe Key Players Polycystic Ovary Syndrome Treatment Revenue (2018-2019) (Million US$)
Table Europe Key Players Polycystic Ovary Syndrome Treatment Market Share (2018-2019)
Table Europe Polycystic Ovary Syndrome Treatment Market Size by Type 2014-2019 (Million US$)
Table Europe Polycystic Ovary Syndrome Treatment Market Share by Type 2014-2019
Table Europe Polycystic Ovary Syndrome Treatment Market Size by Application 2014-2019 (Million US$)
Table Europe Polycystic Ovary Syndrome Treatment Market Share by Application 2014-2019
Figure China Polycystic Ovary Syndrome Treatment Market Size 2014-2019 (Million US$)
Table China Key Players Polycystic Ovary Syndrome Treatment Revenue (2018-2019) (Million US$)
Table China Key Players Polycystic Ovary Syndrome Treatment Market Share (2018-2019)
Table China Polycystic Ovary Syndrome Treatment Market Size by Type 2014-2019 (Million US$)
Table China Polycystic Ovary Syndrome Treatment Market Share by Type 2014-2019
Table China Polycystic Ovary Syndrome Treatment Market Size by Application 2014-2019 (Million US$)
Table China Polycystic Ovary Syndrome Treatment Market Share by Application 2014-2019
Figure Japan Polycystic Ovary Syndrome Treatment Market Size 2014-2019 (Million US$)
Table Japan Key Players Polycystic Ovary Syndrome Treatment Revenue (2018-2019) (Million US$)
Table Japan Key Players Polycystic Ovary Syndrome Treatment Market Share (2018-2019)
Table Japan Polycystic Ovary Syndrome Treatment Market Size by Type 2014-2019 (Million US$)
Table Japan Polycystic Ovary Syndrome Treatment Market Share by Type 2014-2019
Table Japan Polycystic Ovary Syndrome Treatment Market Size by Application 2014-2019 (Million US$)
Table Japan Polycystic Ovary Syndrome Treatment Market Share by Application 2014-2019
Figure Southeast Asia Polycystic Ovary Syndrome Treatment Market Size 2014-2019 (Million US$)
Table Southeast Asia Key Players Polycystic Ovary Syndrome Treatment Revenue (2018-2019) (Million US$)
Table Southeast Asia Key Players Polycystic Ovary Syndrome Treatment Market Share (2018-2019)
Table Southeast Asia Polycystic Ovary Syndrome Treatment Market Size by Type 2014-2019 (Million US$)
Table Southeast Asia Polycystic Ovary Syndrome Treatment Market Share by Type 2014-2019
Table Southeast Asia Polycystic Ovary Syndrome Treatment Market Size by Application 2014-2019 (Million US$)
Table Southeast Asia Polycystic Ovary Syndrome Treatment Market Share by Application 2014-2019
Figure India Polycystic Ovary Syndrome Treatment Market Size 2014-2019 (Million US$)
Table India Key Players Polycystic Ovary Syndrome Treatment Revenue (2018-2019) (Million US$)
Table India Key Players Polycystic Ovary Syndrome Treatment Market Share (2018-2019)
Table India Polycystic Ovary Syndrome Treatment Market Size by Type 2014-2019 (Million US$)
Table India Polycystic Ovary Syndrome Treatment Market Share by Type 2014-2019
Table India Polycystic Ovary Syndrome Treatment Market Size by Application 2014-2019 (Million US$)
Table India Polycystic Ovary Syndrome Treatment Market Share by Application 2014-2019
Figure Central & South America Polycystic Ovary Syndrome Treatment Market Size 2014-2019 (Million US$)
Table Central & South America Key Players Polycystic Ovary Syndrome Treatment Revenue (2018-2019) (Million US$)
Table Central & South America Key Players Polycystic Ovary Syndrome Treatment Market Share (2018-2019)
Table Central & South America Polycystic Ovary Syndrome Treatment Market Size by Type 2014-2019 (Million US$)
Table Central & South America Polycystic Ovary Syndrome Treatment Market Share by Type 2014-2019
Table Central & South America Polycystic Ovary Syndrome Treatment Market Size by Application 2014-2019 (Million US$)
Table Central & South America Polycystic Ovary Syndrome Treatment Market Share by Application 2014-2019
Table Sanofi Company Details
Table Sanofi Revenue in Polycystic Ovary Syndrome Treatment Business 2014-2019 (Million US$)
Figure Sanofi Revenue Growth Rate in Polycystic Ovary Syndrome Treatment Business (2014-2019)
Table Sanofi Recent Development
Table Novartis AG Company Details
Table Novartis AG Revenue in Polycystic Ovary Syndrome Treatment Business 2014-2019 (Million US$)
Figure Novartis AG Revenue Growth Rate in Polycystic Ovary Syndrome Treatment Business (2014-2019)
Table Novartis AG Recent Development
Table Teva Pharmaceutical Industries Limited  Company Details
Table Teva Pharmaceutical Industries Limited  Revenue in Polycystic Ovary Syndrome Treatment Business 2014-2019 (Million US$)
Figure Teva Pharmaceutical Industries Limited  Revenue Growth Rate in Polycystic Ovary Syndrome Treatment Business (2014-2019)
Table Teva Pharmaceutical Industries Limited  Recent Development
Table Addex Therapeutics Ltd.  Company Details
Table Addex Therapeutics Ltd.  Revenue in Polycystic Ovary Syndrome Treatment Business 2014-2019 (Million US$)
Figure Addex Therapeutics Ltd.  Revenue Growth Rate in Polycystic Ovary Syndrome Treatment Business (2014-2019)
Table Addex Therapeutics Ltd.  Recent Development
Table BIOCAD Company Details
Table BIOCAD Revenue in Polycystic Ovary Syndrome Treatment Business 2014-2019 (Million US$)
Figure BIOCAD Revenue Growth Rate in Polycystic Ovary Syndrome Treatment Business (2014-2019)
Table BIOCAD Recent Development
Table Merck KGaA Company Details
Table Merck KGaA Revenue in Polycystic Ovary Syndrome Treatment Business 2014-2019 (Million US$)
Figure Merck KGaA Revenue Growth Rate in Polycystic Ovary Syndrome Treatment Business (2014-2019)
Table Merck KGaA Recent Development
Table AstraZeneca plc. Company Details
Table AstraZeneca plc. Revenue in Polycystic Ovary Syndrome Treatment Business 2014-2019 (Million US$)
Figure AstraZeneca plc. Revenue Growth Rate in Polycystic Ovary Syndrome Treatment Business (2014-2019)
Table AstraZeneca plc. Recent Development
Table Bristol Myers Squibb Co.  Company Details
Table Bristol Myers Squibb Co.  Revenue in Polycystic Ovary Syndrome Treatment Business 2014-2019 (Million US$)
Figure Bristol Myers Squibb Co.  Revenue Growth Rate in Polycystic Ovary Syndrome Treatment Business (2014-2019)
Table Bristol Myers Squibb Co.  Recent Development
Table Ferring Pharmaceuticals, Inc. Company Details
Table Ferring Pharmaceuticals, Inc. Revenue in Polycystic Ovary Syndrome Treatment Business 2014-2019 (Million US$)
Figure Ferring Pharmaceuticals, Inc. Revenue Growth Rate in Polycystic Ovary Syndrome Treatment Business (2014-2019)
Table Ferring Pharmaceuticals, Inc. Recent Development
Table Crinetics Pharmaceuticals, Inc. Company Details
Table Crinetics Pharmaceuticals, Inc. Revenue in Polycystic Ovary Syndrome Treatment Business 2014-2019 (Million US$)
Figure Crinetics Pharmaceuticals, Inc. Revenue Growth Rate in Polycystic Ovary Syndrome Treatment Business (2014-2019)
Table Crinetics Pharmaceuticals, Inc. Recent Development
Table Global Polycystic Ovary Syndrome Treatment Market Size by Regions (Million US$) 2019-2025
Figure Global Polycystic Ovary Syndrome Treatment Market Size Share by Regions (2019-2025)
Figure Global Polycystic Ovary Syndrome Treatment Market Size Share by Regions in 2025
Figure North America Polycystic Ovary Syndrome Treatment Market Size Forecast (2019-2025)(Million USD)
Figure Europe Polycystic Ovary Syndrome Treatment Market Size Forecast (2019-2025)(Million USD)
Figure China Polycystic Ovary Syndrome Treatment Market Size Forecast (2019-2025)(Million USD)
Figure Japan Polycystic Ovary Syndrome Treatment Market Size Forecast (2019-2025)(Million USD)
Figure Southeast Asia Polycystic Ovary Syndrome Treatment Market Size Forecast (2019-2025)(Million USD)
Figure India Polycystic Ovary Syndrome Treatment Market Size Forecast (2019-2025)(Million USD)
Figure Central & South America Polycystic Ovary Syndrome Treatment Market Size Forecast (2019-2025)(Million USD)
Table Global Polycystic Ovary Syndrome Treatment Market Size by Product (2019-2025) (Million US$)
Figure Global Polycystic Ovary Syndrome Treatment Market Size by Product (2019-2025)
Figure Global Polycystic Ovary Syndrome Treatment Market Size by Product in 2025
Table Global Polycystic Ovary Syndrome Treatment Market Size by Application (2019-2025) (Million US$)
Figure Global Polycystic Ovary Syndrome Treatment Market Size by Application (2019-2025)
Figure Global Polycystic Ovary Syndrome Treatment Market Size by Application in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources


【掲載企業】

Sanofi、Novartis AG、Teva Pharmaceutical Industries Limited 、Addex Therapeutics Ltd. 、BIOCAD、Merck KGaA、AstraZeneca plc.、Bristol Myers Squibb Co. 、Ferring Pharmaceuticals, Inc.、Crinetics Pharmaceuticals, Inc.

★調査レポート[多嚢胞性卵巣症候群治療の世界市場：規模・現状・予測2019-2025] (コード：DATA909X18844)販売に関する免責事項を必ずご確認ください。
★調査レポート[多嚢胞性卵巣症候群治療の世界市場：規模・現状・予測2019-2025]についてメールでお問い合わせ
◆関連市場調査レポート◆
  • 多嚢胞性卵巣症候群（PCOS）治療法の世界市場：規模・現状・予測2019-2025
    DATA909X18843 / QYResearch / 2019年11月25日 / ※当調査レポートでは、多嚢胞性卵巣症候群（PCOS）治療法の世界市場について調査・分析し、多嚢胞性卵巣症候群（PCOS）治療法の世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別（経口避妊薬、排卵誘発剤、顔面発毛抑制剤、インスリン感作剤）、用途別（病院、診療所、その他）、地域別（北米、ヨーロッパ、中国、日本国内、東南アジア、インド、中南米）に区分して市場規模を算出しました。 ・レポートの概要 ・世界の多嚢胞性卵巣症候群（PCOS）治療法市場動向 ・主要企業別マーケットシェア ・多嚢胞性卵巣症候群（PCOS）治療法の種類別市場規模2014-2019 （経口避妊薬、排卵誘発剤、顔面発毛抑制剤、インスリン感作剤） ・多嚢胞性卵巣症候群（PCOS）治療法の用途別市場規模2014-2019 （病院、診療所、その他） ・多嚢胞性卵巣症候群（PCOS）治療法の北米市場：主要企業・種類別/用途別市場規模 ・多嚢胞性卵巣症候群（PCOS）治療法のヨーロッパ市場：主要企業・種類別/用途別市場規模...Polycystic ovarian syndrome (PCOS) is one of the most common endocrine disorders among women of reproductive age. In 2018, the global Polycystic Ovarian Syndrome (PCOS) Therapeutics market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025. This report focuses on the global Polycystic Ovarian Syndrome (PCOS) Therapeutics status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Polycystic Ovarian Syndrome (PCOS) Therapeutics development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America....
  • レノックスガストー症候群治療の世界市場：規模・現状・予測2019-2025
    DATA909X18628 / QYResearch / 2019年11月25日 / ※当調査レポートでは、レノックスガストー症候群治療の世界市場について調査・分析し、レノックスガストー症候群治療の世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別（非外科的治療、外科的治療）、用途別（発作、眼球異常、EEG所見、その他）、地域別（北米、ヨーロッパ、中国、日本国内、東南アジア、インド、中南米）に区分して市場規模を算出しました。 ・レポートの概要 ・世界のレノックスガストー症候群治療市場動向 ・主要企業別マーケットシェア ・レノックスガストー症候群治療の種類別市場規模2014-2019 （非外科的治療、外科的治療） ・レノックスガストー症候群治療の用途別市場規模2014-2019 （発作、眼球異常、EEG所見、その他） ・レノックスガストー症候群治療の北米市場：主要企業・種類別/用途別市場規模 ・レノックスガストー症候群治療のヨーロッパ市場：主要企業・種類別/用途別市場規模...Lennox–Gastaut syndrome (LGS) is a complex, rare, and severe childhood-onset epilepsy. It is characterized by multiple and concurrent seizure types, cognitive dysfunction, and slow spike waves on electroencephalogram (EEG). Typically, it presents in children aged 3–5 years and can persist into adulthood.Corpus callosotomy is a surgical procedure used for treating refractory generalized seizures caused due to Lennox-Gastaut syndrome (LGS). However, this surgical procedure involves craniotomy with microdissection. Therefore, companies are focusing on the development of minimally invasive procedures such as MR-guided laser interstitial thermal therapy (MRg-LITT). MRg-LITT has emerged as a safe, effective, and durable alternative of traditional open corpus...
  • HIV関連リポジストロフィー症候群治療の世界市場：規模・現状・予測2019-2025
    DATA909X18542 / QYResearch / 2019年11月25日 / ※当調査レポートでは、HIV関連リポジストロフィー症候群治療の世界市場について調査・分析し、HIV関連リポジストロフィー症候群治療の世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別（特定薬物治療、美容矯正治療）、用途別（病院、専門医院、その他）、地域別（北米、ヨーロッパ、中国、日本国内、東南アジア、インド、中南米）に区分して市場規模を算出しました。 ・レポートの概要 ・世界のHIV関連リポジストロフィー症候群治療市場動向 ・主要企業別マーケットシェア ・HIV関連リポジストロフィー症候群治療の種類別市場規模2014-2019 （特定薬物治療、美容矯正治療） ・HIV関連リポジストロフィー症候群治療の用途別市場規模2014-2019 （病院、専門医院、その他） ・HIV関連リポジストロフィー症候群治療の北米市場：主要企業・種類別/用途別市場規模 ・HIV関連リポジストロフィー症候群治療のヨーロッパ市場：主要企業・種類別/用途別市場規模...Lipodystrophy syndrome groups together three clinical conditions characterized by abnormal body fat distribution: lipoatrophy, lipoaccumulation and a mixed syndrome. In 2018, the global HIV Associated Lipodystrophy Syndrome Treatment market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025. This report focuses on the global HIV Associated Lipodystrophy Syndrome Treatment status, future forecast, growth opportunity, key market and key players. The study objectives are to present the HIV Associated Lipodystrophy Syndrome Treatment development in North America, Europe and Asia-Pacific. The key players covered in this...
  • 世界の多嚢胞性卵巣症候群（PCOS）治療薬市場 2019年
    DATA909X13285 / QYResearch / 2019年11月20日 / ※本調査レポートは、多嚢胞性卵巣症候群（PCOS）治療薬の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、経口避妊薬、抗炎症薬、インスリン抵抗性改善薬、抗高血圧薬、抗肥満薬に、用途別には、病院、クリニックにセグメント区分し、多嚢胞性卵巣症候群（PCOS）治療薬の世界市場を分析しました。 ・エグゼクティブ・サマリー ・多嚢胞性卵巣症候群（PCOS）治療薬の世界市場概要 ・多嚢胞性卵巣症候群（PCOS）治療薬の製造コスト構成分析 ・多嚢胞性卵巣症候群（PCOS）治療薬の開発・製造工場分析 ・主要メーカーの主な指標（生産能力、売上、価格分析） ・多嚢胞性卵巣症候群（PCOS）治療薬の地域別分析（生産、売上、主要メーカー、輸出・輸入） （北米、ヨーロッパ、中国、日本国内、東南アジア、インド） ・多嚢胞性卵巣症候群（PCOS）治療薬のセグメント分析（種類別） （経口避妊薬、抗炎症薬、インスリン抵抗性改善薬、抗高血圧薬、抗肥満薬）...The global Polycystic Ovary Syndrome (PCOS) Drugs market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Polycystic Ovary Syndrome (PCOS) Drugs volume and value at global level, regional level and company level. From a global perspective, this report represents overall Polycystic Ovary Syndrome (PCOS) Drugs market size by analyzing historical data and future prospect. Regionally, this report categorizes the production, apparent consumption, export and import of Polycystic Ovary Syndrome (PCOS) Drugs in North America, Europe, China, Japan, Southeast Asia and...

    • ◆H&Iグローバルリサーチのお客様（例）◆